131I-mIBG therapy in relapsed/refractory neuroblastoma: an old bridge to the future
The <sup>131</sup>I-mIBG therapy plus melphalan is confirmed to be effective to reduce/control tumour burden. Further studies are needed to clarify the role and timing of this treatment and to integrate its role in the strategy of CAR-T cells.
Authors
- Giada Del Baldo (ORCID: https://orcid.org/0000-0003-3540-4331)
- Angela Mastronuzzi (ORCID: https://orcid.org/0000-0002-4408-2373)
- Paolo Tomà (ORCID: https://orcid.org/0000-0002-0158-4760)
- Vittorio Cannatà (ORCID: https://orcid.org/0000-0002-8232-8725)
- Franco Locatelli (ORCID: https://orcid.org/0000-0002-7976-3654)
- Claudio Altini
- Maria Felicia Villani
- Angela Di Giannatale (ORCID: https://orcid.org/0000-0001-8465-3612)
- Iside Alessi
- Milena Pizzoferro (ORCID: https://orcid.org/0000-0002-4135-7626)
- M.C. Garganese
- Maria Antonietta De Ioris (ORCID: https://orcid.org/0000-0002-2113-4505)
- Annalisa Serra (ORCID: https://orcid.org/0000-0003-2505-9888)
- Citterio Davide
- Maria Luisa D’Andrea (ORCID: https://orcid.org/0000-0001-5318-3718)
- Francesca Del Bufalo (ORCID: https://orcid.org/0000-0001-9643-3465)
- Francesco Lanzaro
- F. Fabozzi (ORCID: https://orcid.org/0000-0001-9821-4151)
- Maria Giuseppina Cefalo
Institutions
- University of Campania "Luigi Vanvitelli" (IT)
- Bambino Gesù Children's Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.104541
- Citations
- 3
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.17
Funders
- Ministero della Salute